GH Research announced the promotion of Dr. Velichka “Villy” Valcheva, MD, MSc. to CEO of the Company. Dr. Valcheva succeeds PD Dr. med. Theis Terwey, co-founder of GH Research. Dr. Valcheva joined the company in August 2023 and has served as the Company’s Chief Medical Officer since February 2024 having leadership responsibility, among other things, for the execution of the Company’s clinical development programs.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GHRS:
- GH Research Reports Second Quarter 2024 Financial Results and Provides Business Updates
- GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer
- GH Research PLC trading resumes
- GH Research PLC trading halted, volatility trading pause
- GHRS Upcoming Earnings Report: What to Expect?